Trial Details
COMPLETEDBasic Information
| Clinical ID | c350 |
|---|---|
| Identifier | NCT02862132 |
| Trial Title | Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease|Ulcerative Colitis|Inflammatory Bowel Disease |
| Interventions | DRUG: Vedolizumab |
Participant Information
| Sponsor | Shaare Zedek Medical Center |
|---|---|
| City | Hartford |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2025-01-17 |
|---|---|
| Primary Completion Date | 2025-01-22 |
| Completion Date | 2025-01-22 |